Can a common blood pressure pill fight prostate cancer?
NCT ID NCT06168487
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This early-phase trial is investigating whether telmisartan, a drug typically used for high blood pressure, can be safely given to men with prostate cancer — either alone or alongside standard chemotherapy. Researchers will also look for signs that the drug damages tumor DNA or boosts the immune system's ability to attack cancer cells. The study enrolls 36 adults with prostate cancer who do not need an immediate change in their current treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- telmisartan, a blood pressure drug also known as Micardis, given alone or with standard chemotherapy
- What this could lead to
- If telmisartan proves tolerable and shows signs of anti-tumor activity, it could point toward a new, repurposed treatment option for prostate cancer.
- What could go wrong
- This is a very early phase 1 trial with only 36 participants, focused primarily on safety. It is not designed to prove effectiveness, and telmisartan may not meaningfully impact cancer growth.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dartmouth Health
RECRUITINGLebanon, New Hampshire, 03756, United States
Contact
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A surgical tweak may speed bladder control recovery after prostate removal
- Smarter prostate cancer screening: a blood test that may cut unnecessary biopsies
- Glow-in-the-dark dye may help surgeons spot hidden prostate cancer cells
- Blood DNA fragments and MRI join forces to spot hidden prostate cancer
- Can an AI agent match expert urologists? a major test begins
- Pumping iron to fight cancer's hidden immune toll